Drug resistance in ERBB2 TMD/JMD mutants

Summary
Organism
Homo sapiens (human)
Reactome
R-HSA-9665737
PubChem
R-HSA-9665737
Description
  • With respect to pertuzumab, a therapeutic antibody that block ligand-driven heterodimerization of ERBB2, ERBB2 R678Q is sensitive to pertuzumab, while ERBB2 V659E, ERBB2 G660D, ERBB2 G660R and probably ERBB2 Q709L are resistant (Pahuja et al. 2018).
Click on a node on the pathway to see its details. Glycoproteins are marked with a glycoprotein icon in their name.
Displaying all 4 entries
UniProt ID Protein Name Gene Symbol Pathway Viewer
P04626 Receptor tyrosine-protein kinase erbB-2
  • ERBB2
  • HER2
  • MLN19
  • NEU
  • NGL
view
P07900 Heat shock protein HSP 90-alpha
  • HSP90A
  • HSP90AA1
  • HSPC1
  • HSPCA
view
Q16543 Hsp90 co-chaperone Cdc37
  • CDC37
  • CDC37A
view
Q96RT1 Erbin
  • ERBB2IP
  • ERBIN
  • KIAA1225
  • LAP2
view

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: [email protected]

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.5.0

Last updated: April 6, 2026